'Uncategorized' Category
By Simmons Hanly Conroy | February 28, 2012
Doctors' Social Media Site Sues Republican Candidates Over Facebook Page Use
If your negotiations with Facebook don’t succeed, what do you do? Well, if you are EVERYMD, you sue Rick Santorum, Newt Gingrich and Mitt Romney for patent infringement. During an election year,… Read More
By Simmons Hanly Conroy | January 27, 2012
All FDA Committee Members Should Get to Speak Out Regarding Yaz
In a previous blog post, we shared a news story regarding the FDA and the recent Yaz, Yasmin vote that has come under scrutiny. Is the FDA in bed with big pharmaceutical companies?… Read More
By Simmons Hanly Conroy | January 20, 2012
FDA’s Recent Yaz, Yasmin Vote Under Scrutiny
A recent MedPage Today article printed in EveryDay Health* reports that four FDA medical advisors voting on the risks versus benefits of birth control medications, like Yaz and Yasmin, had ties to Bayer. These FDA… Read More
By Simmons Hanly Conroy | January 3, 2012
Vioxx Settlement in Ohio
A November 23, 2011, Cleveland.com article reports that the state of Ohio will receive a $22.8 million settlement from the Merck, the manufacturer of the recalled drug Vioxx. This is according to… Read More
By Simmons Hanly Conroy | December 5, 2011
Mesothelioma & Asbestos Report: December 5
As a leading mesothelioma law firm, the mesothelioma lawyers from the Firm are committed to offering information on asbestos exposure, mesothelioma diagnosis, and treatment options. Here are a couple of mesothelioma-related stories… Read More
By Simmons Hanly Conroy | November 3, 2011
Yaz Causes More Harm Than Good
The FDA recently released the results of their long-expected study on contraceptives containing drospirenone. It confirmed that women who take contraceptives such as Yaz are 75 percent more likely to suffer serious side effects… Read More
By Simmons Hanly Conroy | October 11, 2011
Avandia Revised Warning Not Adequate, Court Rules
A federal court has agreed with plaintiff’s counsel in a recent ruling that warnings about the dangers of Avandia, a drug used to help manage Type II Diabetes, may have been inadequate, according… Read More
By Simmons Hanly Conroy | September 21, 2011
Simmons Hanly Conroy's Miles for Meso 5K Coming this Weekend
We’re having a busy week here at the firm getting ready for our annual Miles for Meso 5K race, which is happening this Saturday. This year we’ve increased the prize money for… Read More
By Simmons Hanly Conroy | June 3, 2011
FDA to Review Popular Birth Control Pill Yaz
Women who take birth control know doing so comes with a risk of blood clots, especially if they’re a smoker over 35. However, two new studies by the British Medical Journal found that women… Read More
By Simmons Hanly Conroy | June 1, 2011
Health Risks Underestimated for Popular Smoking-Cessation Drug Chantix
A Pharmaceutical watch dog group has reported that the risks of smoking cessation drug Chantix (Varenicline) have been underestimated in the latest round of the Food & Drug Administration reporting. The Institute for… Read More
